Human papillomavirus in cervical screening and vaccination

被引:20
|
作者
Crosbie, Emma J. [1 ]
Kitchener, Henry C. [1 ]
机构
[1] Univ Manchester, St Marys Hosp, Acad Univ Obstet & Gynaecol, Manchester M13 0JH, Lancs, England
来源
CLINICAL SCIENCE | 2006年 / 110卷 / 05期
关键词
cervical cancer; cervical intraepithelial neoplasia; cervical screening; human papillomavirus (HPV); prophylactic vaccination; therapeutic vaccination;
D O I
10.1042/CS20050230
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent decades have witnessed a reduction in the incidence of cervical cancer in countries where screening programmes have achieved broad coverage. The recognized importance of high-risk HPV (human papillomavirus) infection in the aetiology of cervical cancer may introduce a role for HPV DNA testing in cervical screening programmes. Positive HPV DNA tests indicate women at risk of cervical cancer with greater sensitivity, but reduced specificity, compared with exfoliative cytology. Combining HPV testing with cytology may be useful in the triage of minor cytological abnormalities into those requiring referral to colposcopy (HPV positive) compared with those who can be safely managed by cytological surveillance (HPV negative). With its high sensitivity and high-negative-predictive value, HPV testing may also be useful for predicting treatment failure, since residual disease is very unlikely in the event of a negative HPV test. Ultimately, prevention is better than cure, and the advent of HPV prophylactic vaccines may obviate the need for population-based cervical screening programmes in the future. A multivalent vaccine administered to adolescents prior to the onset of sexual activity and boosted at regular intervals throughout their sexually active life may provide protection against type-specific HPV infection, malignant precursors and invasive cervical disease. Several large randomized placebo-controlled trials have been conducted with promising results. For those generations of women already exposed to high-risk HPV infection, therapeutic vaccines may offer advantages over conventional treatment, although much work still needs to be done.
引用
收藏
页码:543 / 552
页数:10
相关论文
共 50 条
  • [21] Adherence to Recommended Cervical Cancer Screening Based on Human Papillomavirus Vaccination Status
    Terk, Daniel
    Bonham, Adrienne
    Caveglia, Sarah
    Li, Dongmei
    Prast, Brendan
    Day, Serena
    [J]. OBSTETRICS AND GYNECOLOGY, 2017, 129 : 6S - 6S
  • [22] Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review
    Elfstrom, Klara Miriam
    Herweijer, Eva
    Sundstrom, Karin
    Arnheim-Dahlstrom, Lisen
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (01) : 120 - 129
  • [23] HUMAN PAPILLOMAVIRUS TESTING IN CERVICAL SCREENING
    TORNE, A
    PUIGTINTORE, LM
    SANCHEZ, E
    [J]. LANCET, 1995, 346 (8977): : 771 - 772
  • [24] Cervical cancer in the human papillomavirus vaccination era
    Tay, Sun-Kuie
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (01) : 3 - 7
  • [25] Human papillomavirus vaccination and cervical cancer risk
    Rahangdale, Lisa
    Mungo, Chemtai
    O'Connor, Siobhan
    Chibwesha, Carla J.
    Brewer, Noel
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [26] Cervical Cancers After Human Papillomavirus Vaccination
    Beller, Uziel
    Abu-Rustum, Nadeem R.
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 113 (02): : 550 - 552
  • [27] Human Papillomavirus Vaccination and Cervical Cancer Risk
    Rahangdale, Lisa
    Mungo, Chemtai
    O'Connor, Siobhan
    Chibwesha, Carla J.
    Brewer, Noel T.
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (04) : 215 - 216
  • [28] Human Papillomavirus Vaccination in the Prevention of Cervical Neoplasia
    Astbury, Katharine
    Turner, Michael J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1610 - 1613
  • [29] Cervical Cancers After Human Papillomavirus Vaccination
    Joura, Elmar A.
    Garland, Suzanne M.
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 114 (01): : 174 - 175
  • [30] Human papillomavirus vaccination and cervical cancer risk
    Rahangdale, Lisa
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 383